Increased Cytoplasmic CD138 Expression Is Associated with Aggressive Characteristics in Prostate Cancer and Is an Independent Predictor for Biochemical Recurrence

<div>Cytoplasmic (a) and membranous (b) CD138 immunostaining and <i>TMPRSS2:ERG.</i></div>

BioMed Research International

fig4

Figure 4

Figure 4: Increased Cytoplasmic CD138 Expression Is Associated with Aggressive Characteristics in Prostate Cancer and Is an Independent Predictor for Biochemical Recurrence 

Figure 4 | Increased Cytoplasmic CD138 Expression Is Associated with Aggressive Characteristics in Prostate Cancer and Is an Independent Predictor for Biochemical Recurrence 